ClinicalTrials.gg
CompletedNCT02816619APA-PARKUpdated Nov 10, 2026

Evaluation of a Personalized Physical Activity Coaching Program in Parkinson's Disease

An interventional study of Personalized Physical Activity coaching program and Free practice of physical activity in Parkinson's Disease, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Treatment

How we know

Updated Nov 10, 2026Now CompletedResults publication added+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Parkinson Disease by University Hospital, Clermont-Ferrand — 5 open to participants now, 5 under way, none of them phase 3. Parkinson Disease · University Hospital, Clermont-Ferrand.

Enrollment
12th of 23
46 · median 46
Started
2016
with 3 others
No phase
18 of 25
4 open now
Registered
11th of 25
by date

Among the 25 studies in Parkinson Disease by University Hospital, Clermont-Ferrand, this one is the 12th largest by enrollment of the 23 interventional ones that give a count, is one of 4 that started in 2016, is one of 18 with no phase, and was the 11th registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

5 of the 25 studies in Parkinson Disease by University Hospital, Clermont-Ferrand are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Parkinson Disease by University Hospital, Clermont-Ferrand, or all of them as a file.
02

Study summary

There is growing interest for physical activity in Parkinson's disease in order to improve mobility and function of these patients. It seems from previous studies that difficulty, intensity and specificity of physical exercises are important parameters conditioning the effect of physical activity on cerebral plasticity and clinical improvement.

Thus, the aim of this study is to evaluate the benefits of a Personalized Physical Activity coaching program, including scheduled and frequent follow up associated with progressive readaptation of exercise intensity depending on individual performances (during 3 months), versus free practice of physical activity in Parkinson's disease.

Read the detailed description

Type of study: a randomized, single-blind, parallel-group, controlled clinical trial.

Number of centers: 1 (Clermont-Ferrand)

Patients

Patients eligible for inclusion will be randomized to one of the two groups:

  • APA + : patients will beneficiate of Personalized Physical Activity coaching program during 3 months (1 hour, twice by week, during 3 months)
  • APA- : patients will do free practice of physical activity during 3 months.

Study Performance Patients will be evaluated 3 times : at J0 (baseline, V1), 3 months after Personalized Physical Activity coaching program (J0+3M, V2), and 3 months after the end of the Personalized Physical Activity coaching program (J0+6M)

V1:

  • Signature of an informed consent form.
  • Demographic and clinical characteristics (sex, age, disease duration, treatments).

V1, V2, V3

  • Neurological evaluation (Unified Parkinson Disease Rating Scale part III score)
  • Evaluation of quality of life (Parkinson's Disease Questionnaire 39-item version (PDQ-39), participation to Daily life activities (Lawton and Brody Activities of Daily Living scale (IADL questionnaire25)
  • Evaluation of performances for specific tests for balance (stabilometry), muscular strength (isometry)
  • Evaluation of cardiorespiratory function (VO2pic et 6 min Walk Test)
  • Evaluation of body composition (lean body mass/fat mass) with DEXA.
  • Dropout rates at V2 and V3
  • Evaluation of the activity with the eMOUVE application in a subgroup of patients.
03

Conditions studied

  • Parkinson's Disease

Keywords

  • Parkinson's disease
  • Physical activity
  • Physical exercise
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical criteria for Parkinson's disease
  • Men or women aged from 18 to 80 years old.
  • Social security coverage.
  • Ability to provide .

Exclusion criteria

Exclusion Criteria:

  • neurological disease other than Parkinson's disease
  • severe depression (Beck Depression Inventory>37) or psychiatric comorbidities (UPDRS I )
  • significant cognitive impairment (\<24)
  • orthopedic impairment with functional restriction
  • to physical exercise
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
46 participants (actual)

Study arms

  • Experimental
    APA+

    APA + : patients will beneficiate of Personalized Physical Activity coaching program during 3 months (1 hour, twice by week, during 3 months)

    Behavioral: Personalized Physical Activity coaching program

  • Other
    APA-

    APA- : patients will do free practice of physical activity during 3 months.

    Behavioral: Free practice of physical activity

Interventions

  • BehavioralPersonalized Physical Activity coaching program
  • BehavioralFree practice of physical activity
06

What researchers measure

Primary outcomes

  1. Change from baseline of the Unified Parkinson Disease Rating Scale part III score

    Time frame: at +3months

Secondary outcomes

  1. Change from baseline of Parkinson's Disease Questionnaire 39-item version score

    Time frame: at +3months

  2. Change from baseline of the Lawton and Brody Activities of Daily Living scale score

    Time frame: at +3months

  3. Change from baseline of the percentage of sedentarity, mild, moderate and intense activity using the eMOUVE application

    Time frame: at +3months

  4. Change from baseline of percentage of sedentarity, mild, moderate and intense activity using the eMOUVE application

    Time frame: at + 6 months

  5. Change from baseline of balancing abilities measured by stabilometry

    Time frame: at +3months

  6. Change from baseline of balancing abilities measured by stabilometry

    Time frame: at + 6 months

  7. Change from baseline of muscular strength measured with isometric test

    Time frame: at +3months

  8. Change from baseline of muscular strength measured with isometric test

    Time frame: at +6months

  9. Change from baseline of VO2pic

    Time frame: at +3months

  10. Change from baseline of VO2pic

    Time frame: at + 6 months

  11. Change from baseline of the 6 min Walking Test score

    Time frame: at +3 months

  12. Change from baseline of the 6 min Walking Test score

    Time frame: at + 6 months

  13. Change from baseline of fat and lean body mass measured by DEXA

    Time frame: at +3 months.

  14. Change from baseline fat and lean body mass measured by DEXA

    Time frame: at +6 months.

  15. dropout rates

    Time frame: at +3 months

  16. dropout rates

    Time frame: at +6 months

07

Study locations

1 site
  • CHU Clermont-Ferrand
    Clermont-Ferrand, 63003, France
08

References and documents

Publications

  • Zanchet C, Lambert C, Boyer T, Pereira B, Derost P, Debilly B, Duclos M, Boisseau N, Marques A. Effect of an adapted physical activity program in Parkinson's disease: A randomized controlled study (APA-Park). Parkinsonism Relat Disord. 2025 May;134:107777. doi: 10.1016/j.parkreldis.2025.107777. Epub 2025 Mar 10. PubMed 40088781 ↗
  • Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3. PubMed 38588457 ↗
  • Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2. PubMed 36602886 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2016 to primary completion in Jun 2018, 27 months.

Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's 27 months is above that.

Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2016
First posted
Jun 28, 2016
StartActual
Mar 24, 2016
Primary completionActual
Jun 30, 2018
CompletionActual
Sep 15, 2018
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Status unknown→Completed
changed Nov 10, 2026
Enrollment
50 (estimated)→46 (actual)
Nov 10, 2026
Publications
Results publication added: Zanchet C, Lambert C, Boyer T, Pereira B, Derost P, Debilly B, Duclos M, Boisseau N, Marques A. Effect of an adapted physical activity program in Parkinson's d… PubMed 40088781 ↗. 2 publications citing this study linked from PubMed
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Status unknown→Completed
    Publications Results publication added: Zanchet C, Lambert C, Boyer T, Pereira B, Derost P, Debilly B, Duclos M, Boisseau N, Marques A. Effect of an adapted physical activity program in Parkinson's d… PubMed 40088781 ↗. 2 publications citing this study linked from PubMed
    Enrollment 50 (estimated)→46 (actual)
    + 4 other changes: verification date, date precision, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT02816619
Collaborators
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques, UFR STAPS
Responsible party
Sponsor
First posted
Jun 28, 2016
Start date
Mar 24, 2016
Primary completion
Jun 30, 2018
Completion
Sep 15, 2018
Last update
Nov 10, 2026
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion